← Eichor
Condition: Pkp2 Acm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pkp2 Acm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated A
Phase 1 · 7 location(s) · Tenaya Therapeutics · NCT06228924A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
Phase N/A · 6 location(s) · Lexeo Therapeutics · NCT06976606Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)
Phase N/A · 21 location(s) · Tenaya Therapeutics · NCT06311708PKP2-ACM Natural History Study
Phase N/A · 3 location(s) · Rocket Pharmaceuticals Inc. · NCT06644742A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-A
Phase 1 · 3 location(s) · Rocket Pharmaceuticals Inc. · NCT05885412
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.